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 Most nuclear medicine staff will know that the phenomenon of radioactivity was 
discovered by a Frenchman, Henri Becquerel [ 1 ]. However very few are aware that 
an Englishman nearly beat him to it. Silvanus Thompson was professor of physics 
at Finsbury Technical College in London and in 1896 he, like Becquerel, had been 
investigating the properties of certain phosphorescent minerals [ 2 ]. On 26th 
February he wrote to George Stokes, who was the President of The Royal Society, 
saying that he had discovered that uranium nitrate produced rays that penetrated 
paper and blackened a photographic plate. Stokes replied on 29th February advising 
him to publish without delay, but by 2nd March it was too late because on that day 
Becquerel presented his similar fi ndings to the Academy of Sciences in Paris [ 2 ]. 
Nevertheless Sylvanus Thompson did make a contribution to medical imaging 
because in 1897 he became the fi rst President of the Roentgen Society which later 
became the British Institute of Radiology [ 2 ]. 
 Ernest Rutherford was born in New Zealand, but in 1895 he came to England to 
study in Cambridge under another Thompson, J.J. Thompson who discovered the 
electron. Here Rutherford identifi ed two different components of the Becquerel 
radiation which he called alpha and beta rays [ 1 ]. In 1898 Rutherford took a post 
at McGill University in Montreal where, with Frederick Soddy, he investigated 
radioactive series and developed the disintegration theory of radioactivity [ 1 ]. 
However in 1907 he returned to the UK to take a position as Professor of Physics 
at Manchester University. Here, with Hans Geiger and Ernest Marsden, he per-
formed the famous experiments on alpha particle scattering which led to him 
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proposing the nuclear theory of the atom. For this he was awarded the Nobel Prize 
in Chemistry in 1908 and in 1919 he became Professor of Physics in Cambridge 
[ 1 ]. For this work he is often known as the ‘Father of Nuclear Physics’. Frederick 
Soddy returned to England to work at University College London where he and 
William Ramsay identifi ed the alpha particle as a helium nucleus. In 1904 Soddy 
became a lecturer in physical chemistry at Glasgow University where he formu-
lated the concept of isotopes of elements and for this he was awarded the Nobel 
Prize in Chemistry in 1921 [ 1 ]. 
 One of Rutherford’s students in Manchester in 1911 was a Hungarian chemist, 
George de Hevesy. Rutherford set him the task of trying to chemically separate the 
radioactive radium D from non-radioactive lead in pitchblende. His failure to do this 
led him to the conclusion that radium D must be an isotope of lead which would 
make an ideal tracer for stable lead [ 3 ]. De Hevesy is credited with the fi rst ever use 
of a radioactive tracer when he added some radium D to the left-overs of a meal in 
his digs. When he was able to detect the radioactivity in the food that his landlady 
served up later in the week he was able to demonstrate that she was recycling old 
food rather than serving up fresh as she claimed [ 3 ]. De Hevesy subsequently went 
on to use his radioactive isotopes for more serious purposes as tracers in chemical 
reactions, in plants and then in animals [ 1 ]. For this work he received the Nobel 
Prize in Chemistry in 1943 and it is no wonder that he is known as the ‘Father of 
Nuclear Medicine’ [ 3 ]. 
 In 1903 William Crookes, working in London, developed the fi rst scintillation 
detector using zinc sulphide and this was used as the basis of scintillation detectors 
until it was superseded by sodium iodide some 40 years later [ 4 ]. However many 
early studies used a Geiger counter which was invented by Hans Geiger in 
Manchester in 1908 and later improved by Geiger and Walther Müller [ 4 ]. It is still 
used today as a versatile radiation detector. 
 The earliest nuclear medicine studies were performed without any imaging, just 
using blood or urine samples or external counting, initially with Geiger counters 
and later with scintillation detectors. One of the standard reference works for these 
studies was written by Norman Veall and Herbert Vetter in 1958 [ 5 ]. Norman Veall 
was a medical physicist at Hammersmith Hospital and then at Guy’s Hospital who 
later became head of the Radioisotope Section at the MRC Clinical Research Centre 
at Northwick Park Hospital. He was talented at developing new equipment and pio-
neering its use for a wide variety of nuclear medicine studies. He developed the 
technique of measuring glomerular fi ltration rate using  51 Cr EDTA and pioneered 
techniques for thyroid function, blood fl ow, cardiac output and many others [ 6 ]. 
 The fi rst nuclear medicine study that produced anything like an ‘image’ of organ 
function was performed in Liverpool. In 1948 George Ansell and Joseph Rotblat 
used some of the fi rst  131 I produced from the new reactor at Harwell to map the dis-
tribution of iodine uptake in a patient’s thyroid [ 7 ]. For this they used a collimated 
Geiger counter that was manually positioned at different positions over the patient’s 
neck. Like many other physicists Rotblat had worked on the Manhattan project dur-
ing the war, but he quickly left the project on moral grounds and returned to his 
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research in nuclear physics at Liverpool University. He became interested in the 
medical uses of radiation because he was determined that his work should be used 
for peace not war. In 1949 he became Professor of Physics at St Bartholomew’s 
Hospital in London. In 1957, along with Bertrand Russell, Albert Einstein and oth-
ers, he founded the Pugwash Conferences on Science and World Affairs, an organ-
isation of scientists working for peace, and in 1995 he was awarded the Nobel Peace 
prize [ 1 ]. 
 Automation of this mapping process led to development of the rectilinear scan-
ner and the fi rst British scanner was constructed in 1951 at the Royal Cancer 
Hospital in Sutton (now the Royal Marsden Hospital) by Val Mayneord. It could 
scan a Geiger counter repeatedly backwards and forwards over a small area building 
up a display on a cathode ray tube display [ 4 ]. In 1957 John Mallard at the 
Hammersmith Hospital produced a larger scanner with two scintillation detectors 
and a novel colour display [ 8 ]. This may have been the fi rst whole-body clinical 
rectilinear scanner in Europe [ 9 ]. It was used for  131 I thyroid imaging and also for 
coincidence detection of positron emitting radionuclides in the brain [ 8 ,  9 ]. The 
existence of positrons and the phenomenon of positron-electron annihilation had 
been predicted by Paul Dirac whist working in Cambridge and he received the 
Nobel Prize for Physics in 1933 [ 1 ]. 
 The fi rst gamma camera in Europe was made by Ekco Electronics of Southend- 
on- Sea (formerly E.K. Cole Ltd). It improved on Anger’s original design by having 
a storage oscilloscope display so that the image could be viewed in real time. The 
prototype was tested by John Mallard and Melvyn Myers at the Hammersmith 
Hospital in 1963 [ 9 ]. In 1965 John Mallard became Professor of Medical Physics at 
the University of Aberdeen and in 1967 they installed their fi rst commercial gamma 
camera made by Nuclear Enterprises of Edinburgh [ 9 ]. In 1973 Mallard’s Department 
developed the Aberdeen Section Scanner which was able to produce single tomo-
graphic slices of the brain from a pair of scintillation counters which scanned and 
then rotated around the patient’s head [ 9 ]. In 1978 the Aberdeen department also 
developed a gamma camera SPECT system by mounting a Nuclear Enterprises 
gamma camera on a rotating gantry [ 9 ]. Nuclear Enterprises had started making 
gamma cameras after they purchased the nuclear instrumentation section of Ekco 
Electronics and subsequently Scintronix, another Edinburgh Company, continued 
development of a Scottish gamma camera. Figure  5.1 shows a Nuclear Enterprises 
gamma camera in use in Manchester Royal Infi rmary about 1970.
 Since the era of global equipment manufacturers, the opportunities for major 
developments in equipment by hospital physicists has largely disappeared. However, 
UK physicists have continued to play a vital role in developments and quality 
improvements in nuclear medicine procedures. Their contributions have often been 
as scientifi c and technical support to particular clinical problems, so it is more 
appropriate to mention them in the relevant clinical applications chapters of this 
book. 
 In 1994 the British Nuclear Medicine Society inaugurated a medal in memory of 
the pioneering work done by Norman Veall. The Norman Veall Medal is awarded 
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annually to a clinical scientist who has made an outstanding contribution to the sci-
ence and/or practice of nuclear medicine in the United Kingdom [ 10 ]. The list of 
recipients of the Norman Veall medal is therefore a good indication of some of the 
physicists and other scientists who have made important contributions to nuclear 
medicine in the UK in recent years. Recipients include Terry Jones and John Clark 
from the Hammersmith Hospital, John Mallard and Peter Sharpe from Aberdeen, 
Roger Ekins and Andrew Todd-Pokropek from University College Hospital, David 
Barber from Sheffi eld, John Fleming from Southampton, Alex Houston from 
Portsmouth, Peter Jarritt from Belfast, Malcolm Frier and Alan Perkins from 
Nottingham, Alex Elliott from Glasgow, David Williams from Sunderland, Robert 
Shields and Richard Lawson from Manchester, Steve Mather from Queen Mary 
University London, Glen Blake from Guy’s and St Thomas’ Hospital, Bill Thomson 
from Birmingham and Paul Maltby from Liverpool. These people have been 
involved in many different areas of nuclear medicine and their spread across the 
country shows that scientists continue to make important contributions to nuclear 
medicine throughout the UK. 
 Fig. 5.1  A Nuclear Enterprises gamma camera circa 1970 (Copyright Institute of Physics and 
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 Richard  S.  Lawson  Richard Lawson is now retired, but for 36 years he worked as a medical 
physicist in the Nuclear Medicine Department of Manchester Royal Infi rmary which later became 
the Central Manchester Nuclear Medicine Centre. During that time he has taken a particular inter-
est in renal studies and in teaching nuclear medicine. He was honoured to receive the Silver Medal 
of the Society and College of Radiographers for services to the teaching of radiographers and the 
Norman Veall Medal of the British Nuclear Medicine Society.  
 Nuclear medicine in Manchester Royal Infi rmary started in 1967 when Tito Testa came over 
from Argentina bringing his skills as a nuclear medicine physician to conduct research for the 
Department of Surgical Gastroenterology. Initially radioisotope work was part of the Department 
of Medical Physics headed by Brian Pullan and in 1969 they moved into newly built facilities in a 
so-called ‘Multi- purpose Building’. Robert Shields joined the hospital as medical physicist in 
1971 and Nuclear Medicine became established as a Department in its own right, with Tito being 
appointed as its fi rst consultant in 1974. Working together for over 30 years Tito and Robert have 
led a team of doctors, physicists, radiopharmacists and technologists who built up an international 
reputation for developing new nuclear medicine techniques, collaborating with clinical colleagues 
to introduce them into clinical practice. They have also always been involved with teaching and 
training nuclear medicine staff. In 1970 Tito’s team developed pancreatic scanning techniques 
using  75 Se selenomethionine, fi rst with a rectilinear scanner and later with a gamma camera and a 
computer subtraction technique to remove liver activity. In 1978 Paddy O’Reilly developed the 
technique of diuresis renography which is now used routinely throughout the world. The 
Department also pioneered the use of  123 I hippuran for gamma camera renography and promoted 
the use of nuclear medicine in monitoring kidney transplants. The team wrote a textbook on 
nuclear medicine in urology and nephrology and developed computer software for accurate analy-
sis of renograms. The Department was an early investigator in the use of  99m Tc HMPAO for brain 
perfusion imaging in dementia and an advocate of ventilation lung scans, with research on the use 
of  81m Kr and  99m Tc technegas led by Jackie James. More recently the Department has built up a 
reputation as a centre of excellence for nuclear cardiology led by Parthiban Arumugam and has 
introduced dose reduction techniques in several areas. Mary Prescott took over the reins of the 
Department from Tito when she became Clinical Director in 1999 and, together with Robert, intro-
duced the PET service. In 2009 the Department fi nally moved out of the 40 year old Multi-purpose 
Building into brand new accommodation in the Central Manchester Nuclear Medicine Centre 
which incorporated a dedicated paediatric unit. In 2010 they became the only UK centre outside 
London to introduce a routine  82 Rb PET myocardial perfusion service, reducing both scan times 
and radiation dose for patients. Currently Parthiban Arumugam is the Clinical Director, Christine 
Tonge leads the physics team and Beverley Ellis heads the radiopharmacy. 
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